260 related articles for article (PubMed ID: 12786889)
1. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma.
Umekita Y; Yoshida H
Histopathology; 2003 Jun; 42(6):541-5. PubMed ID: 12786889
[TBL] [Abstract][Full Text] [Related]
2. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: an immunohistochemical study.
Umekita Y; Yoshida H
Pathol Int; 2000 Jul; 50(7):527-30. PubMed ID: 10886733
[TBL] [Abstract][Full Text] [Related]
4. Expression of maspin predicts poor prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2002 Aug; 100(4):452-5. PubMed ID: 12115529
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of tumor suppressor gene maspin in breast cancer.
Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
[TBL] [Abstract][Full Text] [Related]
6. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
[TBL] [Abstract][Full Text] [Related]
7. Tubular carcinoma and grade 1 (well-differentiated) invasive ductal carcinoma: comparison of flat epithelial atypia and other intra-epithelial lesions.
Kunju LP; Ding Y; Kleer CG
Pathol Int; 2008 Oct; 58(10):620-5. PubMed ID: 18801081
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of maspin expression in breast cancer.
Lee MJ; Suh CH; Li ZH
J Korean Med Sci; 2006 Apr; 21(2):309-14. PubMed ID: 16614520
[TBL] [Abstract][Full Text] [Related]
9. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast.
Maass N; Teffner M; Rösel F; Pawaresch R; Jonat W; Nagasaki K; Rudolph P
J Pathol; 2001 Oct; 195(3):321-6. PubMed ID: 11673829
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3ζ promoted invasion and lymph node metastasis of breast invasive ductal carcinoma with HER2 overexpression.
Wan D; Zhang Y; Yu Q; Li F; Zhuo J
Pathol Res Pract; 2021 Nov; 227():153619. PubMed ID: 34560418
[TBL] [Abstract][Full Text] [Related]
11. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
12. Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancer.
Kim DH; Yoon DS; Dooley WC; Nam ES; Ryu JW; Jung KC; Park HR; Sohn JH; Shin HS; Park YE
Histopathology; 2003 Jan; 42(1):37-42. PubMed ID: 12493023
[TBL] [Abstract][Full Text] [Related]
13. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
14. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
Zhang B; Liu FF; Ma YJ; Gu F
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
[TBL] [Abstract][Full Text] [Related]
15. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ-like structures in metastatic breast carcinoma.
Kordek R
Pathol Res Pract; 2005; 200(11-12):831-4. PubMed ID: 15792128
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.
Rohilla M; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2015 Oct; 15(5):335-42. PubMed ID: 25700939
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2010 Feb; 183(3):455-61. PubMed ID: 19944674
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.
Umekita Y; Takasaki T; Yoshida H
Virchows Arch; 1994; 424(5):491-4. PubMed ID: 7913368
[TBL] [Abstract][Full Text] [Related]
20. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
